2025年度（令和7）

A 欧文

• Harada J, Mitsunari K, Fukushima H, Kurata H, Nakamura Y, Matsuo T, Ohba K, Mochizuki Y, Imamura R. Are Meteorological Factors, Seasons, and Time of Onset Associated With Acute Scrotum? A Comparative Study of Testicular Torsion and Torsion of the Appendix Testis or Epididymis. Sage Open Pediatr, 12, 30502225251325657, 2025
• Oki M, Ohba K, Honda H, Mori S, Kakita S, Araki K, Mitsunari K, Matsuo T, Mochizuki Y, Imamura R: A case of primary malignant melanoma of the ureter. Int Cancer Conf J. 14, 229-234, 2025
• Honda H, Matsuo T, Ito H, Kakita S, Mori S, Araki K, Mitsunari K, Ohba K, Mochizuki Y, Imamura R. Association Between Endogenous Equol Production and the Onset of Overactive Bladder in Postmenopausal Women. J Clin Med, 14(12), 4183, 2025
• Nakamura Y, Mitsunari K, Imamura R. Editorial Comment to Impact and Risk Factors of Diagnostic Delay in Patients With Testicular Cancer: A Multicenter Retrospective Study. Int J Urol, 32(11), 1602-1603, 2025
• Harada J, Mitsunari K, Kakita S, Fukushima H, Kawamura H, Kurata H, Matsuda T, Motokawa M, Ito I, Araki K, Nakamura Y, Matsuo T, Dateki S, Kihara T, Ohba K, Mochizuki Y, Imamura R. Clinical Predictors of Response to Testosterone Replacement Therapy in Boys With Micropenis: A Retrospective Study Focusing on Penile Morphology and Hormonal Factors. Int J Urol, 32(11), 1670-1676, 2025
• Nakamura Y, Fukushima H, Kurata H, Harada J, Araki K, Mitsunari K, Matsuo T, Ohba K, Mochizuki Y, Imamura R. Early emergence of neuroendocrine prostate cancer during triplet therapy for high-volume metastatic castration-sensitive prostate cancer. Int Canc Conf J, 2025
• Yamada S, Amamoto K, Maekawa N, Hara K,　Iwata T, Imasato Y, Matsuo T, Furukawa M, Imamura R. Successful Treatment of Granulocyte Colony-Stimulating Factor-Related Aortitis in Prostate Cancer. IJU Case Rep, 0, 1-4, 2025
• Oki M, Ohba K, Mukae Y, Matsuda T, Nakanishi H, Mitsunari K, Matsuo T, Mochizuki Y, Imamura R. Comparison of the Use of Immune Checkpoint Inhibitor/Tyrosine Kinase Inhibitor and Tyrosine Kinase Inhibitor Alone for Patients With Low Risk Metastatic Renal Cell Carcinoma. In Vivo, 39(6), 3445-3452, 2025
• Matsuo T, Imamura R. Editorial Comment on "The Impact of Visceral Fat Accumulation on 24-h Urine Chemistries and Stone-Recurrence in Patients With Urolithiasis". Int J Urol, 32(11), 1668-1669, 2025
• Matsuo T, Miyata Y, Harada J, Itoh I, Matsuda T, Asai A, Kondo T, Kurata H, Sakai S, Itoh H, Mitsunari K, Imamura R. Efficacy of Pembrolizumab as Second or Third-line Therapy for Local Advanced and Metastatic Urothelial Cancer. Anticancer Res, 45(6), 2563-2573, 2025
• Matsuo T, Imamura R. Editorial Comment: Adjustment to an Appropriate Bedtime Improves Nocturia in Older Adults: A Crossover Study. Int J Urol, 32(7), 877-878, 2025
• Matsuo T, Imamura R. Editorial Comments on "Exploring the association between chronic prostatitis and the risk of herpes zoster in a cohort study in Taiwan". Int J Urol, 32(2), 144, 2025
• Matsuo T, Imamura R. Editorial Comment on Underactive bladder as defined by the International Continence Society in the 2023 Japan Community Health Survey. Int J Urol, 32(1), 60, 2025
• Niimi A, Akiyama Y, Tomonori Y, Furuta A, Matsuo T, Tomoe H, Kakizaki H, Matsukawa Y, Ogawa T, Mitsui T, Masumori N, Inamura S, Enomoto Y, Nomiya A, Maeda D, Igawa Y, Kume H, Homma Y. Clinical manifestations of interstitial cystitis and bladder pain syndrome: Analysis of a patient registry in Japan. Int J Urol. 32(1), 103-109, 2025
• Matsuo T, Matsuda T, Mitsunari K, Ohba K, Imamura R. Endoscopic Deflux Injection for Vesicoureteral Reflux in a Renal Allograft Complicated by Recurrent Acute Pyelonephritis: A Case Report. Cureus, 17(12), e98927, 2025
• Ohba K, Osawa T, Kojima T, Hara T, Sugimoto M, Eto M, Minami K, Nakai Y, Ueda K, Naito S, Nonomura N, Murai S, Nishiyama H, Nakanishi H, Mukae Y, Mitsunari K, Matsuo T, Imamura R, Shinohara N. Characteristics of patients with metastatic renal cell carcinoma who do not respond to axitinib treatment. Int J Clin Oncol, 30(4), 781-788, 2025
• Kawada K, Ohba K, Oki M, Mukae Y, Nakanishi H, Mitsunari K, Matsuo T, Mochizuki Y, Imamura R. Amount of Ipsilateral Parenchymal Volume Preserved Is a Key Determinant of Split Renal Function after Robot-Assisted Partial Nephrectomy. J Endourol, 39(5), 482-487, 2025
• Nishimoto K, Kimura G, Sazuka T, Hamamoto S, Nozawa M, Numakura K, Mizokami A, Kondo T, Naito S, Abe T, Ohba K, Nagata M, Onodera S, Ito H, Uemura H. The Effectiveness and Safety Profile of Nivolumab-Plus-Ipilimumab in Previously Untreated Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma (J-ENCORE Study). Int J Urol, 32(8), 961-972, 2025
• Tanegashima T, Shiota M, Akamatsu S, Miyake H, Takahashi M, Oya M, Tsuchiya N, Masumori N, Matsuyama H, Obara W, Shinohara N, Fujimoto K, Nozawa M, Ohba K, Ohyama C, Hashine K, Kamba T, Mita K, Gotoh M, Tatarano S, Fujisawa M, Tomita Y, Mukai S, Ito K, Tokunaga S, Eto M; SNiP‐RCC investigators. GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab. Cancer Sci, 116(12), 3300-3308, 2025
• Shiota M, Nemoto S, Ikegami R, Tanegashima T, Blas L, Miyake H, Takahashi M, Oya M, Tsuchiya N, Masumori N, Kobayashi K, Obara W, Shinohara N, Fujimoto K, Nozawa M, Ohba K, Ohyama C, Hashine K, Akamatsu S, Motoshima T, Mita K, Gotoh M, Tatarano S, Fujisawa M, Tomita Y, Mukai S, Ito K, Eto M. Predictive Model of Objective Response to Nivolumab Monotherapy for Advanced Renal Cell Carcinoma by Machine Learning Using Genetic and Clinical Data: The SNiP-RCC Study. JCO Clin Cancer Inform, 9, e2400167, 2025
• Nezasa M, Kawase M, Washino S, Nishino T, Fukushima H, Iwatani K, Miyagawa T, Shimbo M, Yamasaki T, Ohba K, Miki J, Ishida K, Koie T. Efficacy of Neoadjuvant Hormonal Therapy for High-Risk Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Study Using Propensity Score-Matched Analysis in Japan. Clin Genitourin Cancer, 23(3), 102346, 2025
• Sazuka T, Tatsugami K, Shirotake S, Hamamoto S, Nozawa M, Numakura K, Mizokami A, Kondo T, Naito S, Abe T, Ohba K, Kimura G, Onodera S, Yamaguchi K, Uemura H. Outcomes of Nivolumab-Plus-Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J-ENCORE Study. Int J Urol, 2025, Epub ahead of print.
• Kawase M, Washino S, Nishino T, Yamasaki T, Fukushima H, Iwatani K, Miyagawa T, Shimbo M, Ohba K, Miki J, Nakane K, Koie T. Neoadjuvant Chemohormonal Therapy Versus Pelvic Lymphadenectomy on Biochemical Recurrence in Patients with High- or Very-High-Risk Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy. Diseases, 13(4), 92, 2025

B 邦文

• 原田 淳樹, 大庭 康司郎, 今村 亮一：ロボット支援腹腔鏡下腎盂形成術　臨床泌尿器科79巻8号676-681
• 本多 弘幸、松尾 朋博 、柿田 聖太、森 慎太郎 、荒木 杏平、光成 健輔 、大庭 康司郎 、望月 保志 、今村 亮一：エクオール産生の有無と過活動膀胱との関連について. 日排尿会誌, 35, 563-569, 2025
• 松尾　朋博、今村　亮一：下部尿路症状に対する問診のポイント　泌尿器外科38巻12号
• 松尾　朋博、今村　亮一：夜間頻尿　オールラウンド 外来診療ガイドブック　中山書店, 2025年
• 松尾　朋博、今村　亮一：アンチエイジングの観点から診る夜間頻尿　アンチエイジング医学 日本抗加齢医学会雑誌21巻3号
• 松尾　朋博、今村　亮一：患者満足度を高める過活動膀胱診療の実践に向けて　臨床泌尿器科79巻13号　Page1142-1146
• 大庭　康司郎、今村　亮一：【腹部領域のリンパ節郭清は必要?不要?各疾患におけるリンパ節郭清の実際】泌尿器癌に対する腹部リンパ節郭清の実際と展望　Japanese Journal of Endourology and Robotics　38巻1号 Page99-104
• 大庭　康司郎、望月　保志、今村　亮一：【長期透析の現況・課題と対策】長期透析患者の悪性腫瘍　臨床透析41巻4号 Page437-441
• 大庭　康司郎：淡明細胞型腎癌の周術期薬物療法　オンコロジークリニカルガイド　泌尿器癌薬物療法　南山堂, Page47-51, 2025年

受賞報告